Abstract
Industrial food processing has been linked to various health outcomes including cancer. To examine associations between the degree of food processing and risk of colorectal cancer (CRC) and its sub-sites, data from the European Prospective Investigation into Cancer (EPIC) including 6155 incident CRC cases (n = 450,111 participants), were analyzed. Dietary intakes were assessed using baseline food frequency questionnaires. Foods were classified into culinary ingredients, unprocessed, processed (PFs), and ultra-processed foods (UPFs) according to the Nova classification. Cox proportional hazards models, adjusted for established CRC risk factors, were used to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs) associated with a 10% increase in proportion of consumption (%g/d) of each Nova group. Substitution analysis examined the effect of replacing UPFs and PFs with unprocessed foods on CRC risk. A 10% increase in proportion of UPFs was associated with 6% higher CRC risk (95% CI:1.02–1.10). A positive association was also found between PFs and CRC risk (HR per 10% increase: 1.10 [95% CI, 1.05–1.15]). Conversely, unprocessed food consumption was inversely associated with CRC risk (HR per 10% increase: 0.93[95% CI, 0.90–0.95]). Substitution of 10% of the overall proportion of the diet comprising UPFs or PFs with 10% unprocessed foods was associated with a decreased risk of CRC (HRUPFs: 0.94 [95% CI, 0.90–0.97]; HRPFs: 0.90 [95% CI, 0.86–0.94]). In conclusion, UPF was positively associated with CRC risk while diets richer in unprocessed foods were associated with lower CRC risk. Further studies are needed to understand the mechanisms by which food processing affects CRC risk.
| Original language | English |
|---|---|
| Pages (from-to) | 260-276 |
| Number of pages | 17 |
| Journal | International Journal of Cancer |
| Volume | 157 |
| Issue number | 2 |
| Early online date | 8 Feb 2025 |
| DOIs | |
| Publication status | Published - 15 Jul 2025 |
Bibliographical note
Publisher Copyright:© 2025 UICC.
Funding
This study was supported by Cancer Research UK (C33493/A29678), World Cancer Research Fund International (IIG_FULL_2020_033), and the Institut National du Cancer (INCa number 2021\u2010138). The coordination of EPIC is financially supported by the IARC and the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, which has additional infrastructure support provided by the UK National Institute for Health and Care Research Imperial Biomedical Research Centre. The national cohorts are supported by the Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle G\u00E9n\u00E9rale de l'Education Nationale, Institut National de la Sant\u00E9 et de la Recherche M\u00E9dicale (INSERM; France); German Cancer Aid, German Cancer Research Center (DKFZ), German Institute of Human Nutrition Potsdam\u2010Rehbruecke (DIfE), Federal Ministry of Education and Research (BMBF; Germany); Associazione Italiana per la Ricerca sul Cancro\u2010AIRC\u2010Italy, Compagnia di SanPaolo and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund, Statistics Netherlands (Netherlands); Health Research Fund (FIS)\u2014Instituto de Salud Carlos III (ISCIII), Regional Governments of Andaluc\u00EDa, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology (ICO; Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Sk\u00E5ne and V\u00E4sterbotten (Sweden); and Cancer Research UK (14136 to EPIC\u2010Norfolk; C8221/A29017 to EPIC\u2010Oxford) and Medical Research Council (1000143 to EPIC\u2010Norfolk; MR/M012190/1 to EPIC\u2010Oxford, UK). We acknowledge \u2018the National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands, for their contribution and ongoing support to the EPIC Study\u2019. Fernanda Morales Berstein was supported by a Wellcome Trust PhD studentship in Molecular, Genetic and Lifecourse Epidemiology (224982/Z/22/Z). Emine Koc Cakmak was supported by the Ministry of National Education, T\u00FCrkiye, through the YLSY International Graduate Education Scholarship Programme.
| Funders | Funder number |
|---|---|
| NKR | |
| Ministry of National Education, Türkiye | |
| Netherlands Cancer Registry | |
| Department of Epidemiology and Biostatistics, University of California, San Francisco | |
| Dutch Prevention Funds | |
| Catalan Institute of Oncology | |
| Ligue Contre le Cancer | |
| Imperial College London | |
| University of Maryland School of Public Health | |
| Instituto de Salud Carlos III | |
| Associazione Italiana per la Ricerca | |
| German Institute of Human Nutrition Potsdam‐Rehbruecke | |
| Institut national de la santé et de la recherche médicale | |
| National Institute for Health and Care Research Imperial Biomedical Research Centre | |
| Kræftens Bekæmpelse | |
| LK Research Funds | |
| World Cancer Research Fund | |
| Bundesministerium für Bildung und Forschung | |
| Cancerfonden | |
| Centre International de Recherche sur le Cancer | |
| Dutch ZON (Zorg Onderzoek Nederland | |
| Ministerie van Volksgezondheid, Welzijn en Sport | |
| Health Research Fund | |
| National Research Council | |
| Institut Gustave-Roussy | |
| Consejería de Salud y Familias, Junta de Andalucía | |
| Deutsche Krebshilfe | |
| Deutsches Krebsforschungszentrum | |
| Compagnia di SanPaolo | |
| Mutuelle Générale de l'Education Nationale | |
| Vetenskapsrådet | |
| Medical Research Council | 1000143, MR/M012190/1 |
| Wellcome Trust | 224982/Z/22/Z |
| World Cancer Research Fund International | IIG_FULL_2020_033 |
| County Councils of Skåne | 14136, C8221/A29017 |
| Institut National Du Cancer | 2021‐138 |
| Cancer Research UK | C33493/A29678 |
Keywords
- Colorectal cancer
- EPIC
- Nova classification
- obesity
- UPFs